Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| N-[4-(beta-Cyclohexylureidoethyl)benzensulfonyl] N-Cyclohexylurea | N-[(Cyclohexylamino)carbonyl]-4-[2-[[(cyclohexylamino)carbonyl]amino]ethyl]- benzenesulfonamide; 1-Cyclohexyl-3-[p-[(cyclohexylcarbamoyl)sulfamoyl] phenethyl]urea; N-[p-(beta-Cyclohexylureidoethyl)benzensulfonyl]-N-cyclohexylurea; Glipizide EP Impurity I | 10079-35-3 | C22H34N4O4S | 450.59 | N-[(Cyclohexylamino)carbonyl]-4-[2-[[(cyclohexylamino)carbonyl]amino]ethyl]- benzenesulfonamide; 1-Cyclohexyl-3-[p-[(cyclohexylcarbamoyl)sulfamoyl] ph... |
| BRL-50481 | 3-(N,N-Dimethylsulfonamido)-4-methylnitrobenzene, 5-Nitro-2-N,N-trimethylbenzenesulfonamide | 433695-36-4 | C9H12N2O4S | 244.27 | 3-(N,N-Dimethylsulfonamido)-4-methylnitrobenzene, 5-Nitro-2-N,N-trimethylbenzenesulfonamide
|
| BRL-54443 | 3-(1-Methyl-4-piperidinyl)-1H-indol-5-ol; | 57477-39-1 | C14H18N2O | 230.31 | 3-(1-Methyl-4-piperidinyl)-1H-indol-5-ol;
|
| 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone | USP Cilostazol Related Compound C; | 865792-18-3 | C31H45N9O2 | 575.75 | USP Cilostazol Related Compound C;
|
| 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone-d11 | Cilostazol Related Compound C-d11; | NA | C31H34D11N9O2 | 586.82 | Cilostazol Related Compound C-d11;
|
| Cyclohexyltriphenylphosphonium Bromide | Bromo(cyclohexyl)triphenylphosphorane | 7333-51-9 | C24H26BrP | 425.34 | Bromo(cyclohexyl)triphenylphosphorane
|
| 3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxazolyl Acetic Acid | USP Ciclopirox Related Compound A; | NA | C12H19NO3 | 225.28 | USP Ciclopirox Related Compound A;
|
| Cycloheximide | 4-[(2R)-2-[(1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-2,6-piperidinedione; 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide; Naramycin A; Acti-Aid; Acti-dione; Acti-dione BR; Acti-dione PM; Acti-dione TGF; Actidion; CHX; Cicloheximide; FT 3422-2; NSC 185; Naramycin; Naramycin Microcapsule D 80; Naramycin NM-MCU 80; TZA; U 4527; beta-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide; | 66-81-9 | C15H23NO4 | 281.35 | 4-[(2R)-2-[(1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-2,6-piperidinedione; 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimid... |
| N-Cyano-3-(cyanoamino)-N’-methyl-7,8-dithia-2,4,11-triazadodec-2-en-12-imidamide (Cimetidine Impurity) | SKF 82964; Cimetidine EP Impurity H | 74886-59-2 | C10H18N8S2 | 314.43 | SKF 82964; Cimetidine EP Impurity H
|
| N-Cyano-3-(cyanoamino)-N’-methyl-7,8-dithia-2,4,11-triazadodec-2-en-12-imidamide-D6 (Cimetidine Impurity) | SKF 82964-D6 | NA | C10H12D6N8S2 | 320.47 | SKF 82964-D6
|
Page 1424 of 10017